Sign in

CIK 0000886163 · Large accelerated filer

LIGAND PHARMACEUTICALS INC

Sign in to watch
Tickers
LGND LGNDZ LGNXZ LGNYZ LGNZZ
Exchange
Nasdaq, OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
770160744
Phone
858-550-7500
Business address
3911 SORRENTO VALLEY BLVD, SUITE 110, SAN DIEGO, CA, 92121
Former names
LIGAND PHARMACEUTICALS

Securities

  • LGND Common Stock Nasdaq
  • LGNDZ Common stock OTC
  • LGNXZ Common stock OTC
  • LGNYZ Common stock OTC
  • LGNZZ Common stock OTC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$6,585,411
in 7 filings, $4.5M under 10b5-1 plans

Net −$6,585,411. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Reardon Andrew −$4.5M CLO & Secretary sold 32% of stake
  2. Aryeh Jason −$1.7M Director sold 5% of stake
  3. Zimmermann Martine −$342K Director sold 24% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-02-09 Sabba Stephen L Director Option exercise +7,335 $10.12 $74K 31,766
2021-02-09 Sabba Stephen L Director Option exercise +7,335 $12.53 $92K 39,101
2021-02-09 Sabba Stephen L Director Sale −556 $208.00 $116K 38,545
2021-02-09 Sabba Stephen L Director Sale −14,114 $208.55 $2.9M 24,431
2021-02-09 Sabba Stephen L Director Option exercise · Non-Qualified Stock Option (right to buy) −7,335 0
2021-02-09 Sabba Stephen L Director Option exercise · Non-Qualified Stock Option (right to buy) −7,335 0
2021-02-05 HIGGINS JOHN L Chief Executive Officer Option exercise +54,666 $14.47 $791K 340,696
2021-02-05 HIGGINS JOHN L Chief Executive Officer Sale −54,666 $203.40 $11.1M 286,030
2021-02-05 HIGGINS JOHN L Chief Executive Officer Option exercise +60,000 $10.05 $603K 346,030
2021-02-05 HIGGINS JOHN L Chief Executive Officer Shares withheld for taxes −2,970 $203.03 $603K 343,060
2021-02-05 HIGGINS JOHN L Chief Executive Officer Option exercise · Non-Qualified Stock Option (right to buy) −60,000 0
2021-02-05 HIGGINS JOHN L Chief Executive Officer Option exercise · Non-Qualified Stock Option (right to buy) −54,666 14,334
2021-02-04 Berkman Charles S SVP, Gen. Counsel & Secretary Sale −18,097 $178.50 $3.2M 28,906
2021-02-04 FOEHR MATTHEW W President and COO Option exercise +1,000 $74.42 $74K 168,198
2021-02-04 FOEHR MATTHEW W President and COO Option exercise +44,547 $21.92 $976K 212,745
2021-02-04 FOEHR MATTHEW W President and COO Sale −44,547 $176.86 $7.9M 168,198
2021-02-04 FOEHR MATTHEW W President and COO Option exercise · Employee Stock Option (right to buy) −44,547 20,000
2021-02-04 FOEHR MATTHEW W President and COO Option exercise · Employee Stock Option (right to buy) −1,000 63,210
2021-02-03 Berkman Charles S SVP, Gen. Counsel & Secretary Grant or award +3,491 47,003
2021-02-03 Berkman Charles S SVP, Gen. Counsel & Secretary Grant or award · Employee Stock Option (right to buy) +6,955 6,955

Page 35 of 43 · 858 trades